We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants Final Approval for Generic Risperdal
FDA Grants Final Approval for Generic Risperdal
February 3, 2009
The FDA has granted final approval to Teva Pharmaceutical Industries’ ANDA for its generic version of Ortho-McNeil-Janssen Pharmaceuticals’ antipsychotic agent Risperdal 1-mg/mL oral solution.